The 21st Golden Helix Pharmacogenomics Day will be organized in Singapore. The meeting will be co-organized from the Golden Helix Foundation and the Surveillance and Pharmacogenomics Initiative for Adverse Drug Reactions (SAPhIRE) Network and will be held at the Breakthrough Theaterette (Level 4, Matrix Building, Biopolis, Singapore).

This international event is open for biomedical scientists, hospital and general pharmacists, specialists, general practitioners, medical students, laboratory technicians, regulators, healthcare insurers and others interested in pharmacogenomics.

The meeting will feature lectures from local and international speakers on the impact of pharmacogenomics in various medical specialties, focusing in particular on the bioinformatics solutions in pharmacogenomics.  

On behalf of the Organising Committee

The 4th U-PGx Personalized Medicine Day will be organized in Stockholm, Sweden. The meeting will be co-organized from the Golden Helix Foundation and the Karolinska Institutet, both partners of the Ubiquitous Pharmacogenomics (U-PGx) project, funded by the European Commission (H2020-668353). The meeting will be held in the STRIX lecture hall (address: von Eulers väg 4, Karolinska Institutet 171 65 Solna).

This international event is open for clinical pharmacologists, hospital pharmacists, general pharmacists, specialists, general practitioners, medical students, laboratory technicians, regulators, healthcare insurers and others interested in pharmacogenomics.

On behalf of the Organizing Committee

The 5th UPGx Personalized Medicine Day will be organized in Liverpool, UK. The meeting will be co-organized from the Golden Helix Foundation and the University of TLiverpool, both partners of the Ubiquitous Pharmacogenomics (UPGx) project, funded by the European Commission (H2020-668353). 

The event will be held at the Royal Liverpool Hospital postgraduate Medical Centre lecture theatre.

This international event is open for clinical pharmacologists, hospital pharmacists, general pharmacists, specialists, general practitioners, medical students, laboratory technicians, regulators, healthcare insurers and others interested in pharmacogenomics.

On behalf of the Organizing Committee